CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,100,000
- in 1 filing
Net −$3,100,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-08 | Bonstein Sara Chief Financial Officer | Grant or award | +6,657 | 119,929 | ||
| 2025-01-08 | Bonstein Sara Chief Financial Officer | Grant or award · Stock Option (right to buy) | +31,930 | 31,930 | ||
| 2025-01-08 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −1,209 | $65.84 | $80K | 96,306 |
| 2025-01-08 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award 10b5-1 | +5,706 | 102,012 | ||
| 2025-01-08 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +27,370 | 27,370 | ||
| 2025-01-08 | Wise John Drayton Chief Commercial Officer | Sale 10b5-1 | −392 | $66.21 | $26K | 119,192 |
| 2025-01-08 | Wise John Drayton Chief Commercial Officer | Grant or award 10b5-1 | +6,657 | 125,849 | ||
| 2025-01-08 | Wise John Drayton Chief Commercial Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +31,930 | 31,930 | ||
| 2025-01-08 | Lewis William Chair and CEO | Sale | −3,999 | $65.96 | $264K | 372,743 |
| 2025-01-08 | Lewis William Chair and CEO | Grant or award | +22,824 | 395,567 | ||
| 2025-01-08 | Lewis William Chair and CEO | Grant or award · Stock Option (right to buy) | +109,490 | 109,490 | ||
| 2025-01-08 | Smith Michael Alexander Chief Legal Officer | Sale | −1,064 | $66.21 | $70K | 64,578 |
| 2025-01-08 | Smith Michael Alexander Chief Legal Officer | Grant or award | +5,706 | 70,284 | ||
| 2025-01-08 | Smith Michael Alexander Chief Legal Officer | Grant or award · Stock Option (right to buy) | +27,370 | 27,370 | ||
| 2025-01-08 | Adsett Roger Chief Operating Officer | Sale 10b5-1 | −1,882 | $66.10 | $124K | 145,784 |
| 2025-01-08 | Adsett Roger Chief Operating Officer | Grant or award 10b5-1 | +6,657 | 152,441 | ||
| 2025-01-08 | Adsett Roger Chief Operating Officer | Grant or award · Stock Option (right to buy) 10b5-1 | +31,930 | 31,930 | ||
| 2025-01-07 | Flammer Martina M.D. Chief Medical Officer | Sale 10b5-1 | −3,344 | $65.91 | $220K | 102,766 |
| 2025-01-07 | Bonstein Sara Chief Financial Officer | Sale | −3,470 | $65.70 | $228K | 114,736 |
| 2025-01-07 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Sale 10b5-1 | −2,596 | $65.88 | $171K | 97,515 |
Page 33 of 42 · 826 trades